Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

448 public trials 58 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

Phase 3 Study for Efficacy and Safety Outcomes Data in Japanese Patients With Severe Hemophilia A

NCT06224907

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Cardiovascular Diseases, +9 more
Locations
  • Asahikawa Medical University Hospital Hokkaido, Asahikawa, Japan
  • Saitama Medical University Hospital Saitama, Iruma-gun, Japan
  • Nagoya University Hospital Aichi, Nagoya, Japan
  • Tokyo Medical University Hospital Tokyo, Shinjuku-ku, Japan
View Trial Details
Active, Not Recruiting

HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide

NCT04904588

Conditions
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, +30 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Stanford University Stanford, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 39 locations
View Trial Details
Active, Not Recruiting

Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom

NCT02952508

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Central Nervous System Lymphoma, +36 more
Locations
  • Cellectar Biosciences site Los Angeles, California, United States
  • Cellectar Biosciences site Redlands, California, United States
  • Cellectar Biosciences site Washington D.C., District of Columbia, United States
  • Cellectar Biosciences site Jacksonville, Florida, United States
View all 52 locations
View Trial Details
Active, Not Recruiting

Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders

NCT04761770

Conditions
Atypical Chronic Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +18 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Consent Only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent Only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent Only) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Consent only) Commack, New York, United States
View Trial Details
Active, Not Recruiting

HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

NCT06001385

Conditions
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +37 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Honor Health Scottsdale, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
View all 32 locations
View Trial Details
Active, Not Recruiting

A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

NCT04965493

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
Locations
  • Ironwood Physicians, Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • University of California Irvine Medical Center Orange, California, United States
  • Scripps Mercy Hospital San Diego, California, United States
View all 176 locations
View Trial Details
Active, Not Recruiting

Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

NCT03842696

Conditions
Acute Leukemia in Remission, Blast Crisis, Bone Marrow Diseases, +37 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Emory University Atlanta, Georgia, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • University of Michigan Health System Ann Arbor, Michigan, United States
View Trial Details
Active, Not Recruiting

A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

NCT05023980

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
Locations
  • California Research Institute Los Angeles, California, United States
  • Innovative Clinical Research Institute Whittier, California, United States
  • Oncology-Hematology Associates of West Broward Coral Springs, Florida, United States
  • New Jersey Center for Cancer Research Brick, New Jersey, United States
View all 108 locations
View Trial Details
Active, Not Recruiting

Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant

NCT04572815

Conditions
Hematologic Diseases, Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid System Neoplasm, +1 more
Locations
  • City of Hope Comprehensive Cancer Center, Duarte, California, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions